DURAVYU, EyePoint's lead candidate for wet AMD and DME, has demonstrated a compelling durability profile in Phase 2. Read why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results